Autism

NeuroVigil’s iBrain™ in TIME’s “Best Inventions of 2025”

iBrain™ - Copyright © 2025 NeuroVigil, Inc. All Rights Reserved. iBrain™ prototype iBrain™ with two quarters - Copyright © 2025…

3 months ago

Dartmouth’s play2Prevent Lab and Nonprofit Proof Positive Collaborate to Design Mental Health Games for Autistic Youth

NEW YORK, Oct. 9, 2025 /PRNewswire/ -- The play2PREVENT (p2P) Lab at the Geisel School of Medicine at Dartmouth has…

3 months ago

bobo, the AI-Driven Parenting Intelligence Platform, Launches in the United States

Revolutionary technology empowers parents with advanced insights about their children's development, transforming reactive pediatric care into proactive health monitoring WINNIPEG,…

3 months ago

Hipp Health Raises $6.2 Million in Seed Funding

Company Will Utilize Funds for Product Expansion, AI Investments, and Team GrowthSAN FRANCISCO, Oct. 06, 2025 (GLOBE NEWSWIRE) --  Hipp…

3 months ago

Stride Autism Centers Named a Winner of the 2025 Iowa Top Workplaces Award

DES MOINES, Iowa, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Stride Autism Centers, a leading provider of center-based early intervention ABA…

3 months ago

Brain Balance Onboards with ProsperityEHR to Strengthen Care for ADHD, Autism, and Learning Challenges

Partnership equips Brain Balance to scale its national network with a unified EHR that integrates clinical, financial, and operational workflows,…

4 months ago

EGI Launches Next-Generation HD-EEG Platform to Advance Understanding of Brain Function and Stimulation

Innovator of HD-EEG releases world’s most advanced EEG brain monitoring technology for neuroscience research EGI GES 500 Next-Generation HD-EEG Platform…

4 months ago

APhA alarmed by claims of harm from acetaminophen without substantive science

WASHINGTON, Sept. 23, 2025 /PRNewswire/ -- As the medication experts, APhA affirms there has been no new evidence in two…

4 months ago

Beyond Air to Participate in the ROTH 4th Annual Healthcare Opportunities Conference

GARDEN CITY, N.Y., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a…

4 months ago

ORYZON to Sponsor First Phelan-McDermid Syndrome (PMS) Burden of Illness Study

Study led by CureShankAims to characterize the direct and indirect burden of PMS to patients, caregivers, and US healthcare system…

4 months ago